Maxime Y. Tondreau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Maxime Y. Tondreau has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Jean Ruel
Département de Génie Mécanique, Université Laval, Québec, Canada
5 shared publicationsJean-Michel Bourget
Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, FRQS CHU de Quebec Research Centre, Quebec, Canada
5 shared publications- Lucie Germain
Centre de recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, Québec, QC, G1V 0A6, Canada; Department of Surgery, Faculty of Medicine, Université Laval, Québec, QC, G1V 0A6, Canada; CHU de Québec-Université Laval Research Center, Québec, QC, G1J 5B3, Canada
5 shared publications Catherine Tremblay
Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, FRQS CHU de Quebec Research Centre, Quebec, Canada
4 shared publicationsKarine Vallières
Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Division of Regenerative Medicine, CHU de Québec Research Centre - Université Laval, Québec, QC, Canada; Department of Surgery, Faculty of Medicine, Université Laval, Québec, QC, Canada
4 shared publicationsVéronique Laterreur
Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, FRQS CHU de Quebec Research Centre, Quebec, Canada
4 shared publications
Latest Publications
- 28 April 2016
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 11 (9) , 2479-2489
Microstructured human fibroblast-derived extracellular matrix scaffold for vascular media fabrication
In the clinical and pharmacological fields, there is a need for the production of tissue-engineered small-diameter blood vessels. We have demonstrated previously that the extracellular matrix (ECM) produced by fibroblasts can be used as a scaffold to support three-dimensional (3D) growth of another cell type. Thus, a resistant tissue-engineered vascular media can be produced when such scaffolds are used to culture smooth muscle cells (SMCs). The present study was designed to develop an anisotropic fibroblastic ECM sheet that could replicate the physiological architecture of blood vessels after being assembled into a small diameter vascular conduit. Anisotropic ECM scaffolds were produced using human dermal fibroblasts, grown on a microfabricated substrate with a specific topography, which led to cell alignment and unidirectional ECM assembly. Following their devitalization, the scaffolds were seeded with SMCs. These cells elongated and migrated in a single direction, following a specific angle relative to the direction of the aligned fibroblastic ECM. Their resultant ECM stained for collagen I and III and elastin, and the cells expressed SMC differentiation markers. Seven days after SMCs seeding, the sheets were rolled around a mandrel to form a tissue-engineered vascular media. The resulting anisotropic ECM and cell alignment induced an increase in the mechanical strength and vascular reactivity in the circumferential direction as compared to unaligned constructs. Copyright © 2016 John Wiley & Sons, Ltd.
- 28 April 2016
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 11 (9) , 2479-2489
Microstructured human fibroblast-derived extracellular matrix scaffold for vascular media fabrication
In the clinical and pharmacological fields, there is a need for the production of tissue-engineered small-diameter blood vessels. We have demonstrated previously that the extracellular matrix (ECM) produced by fibroblasts can be used as a scaffold to support three-dimensional (3D) growth of another cell type. Thus, a resistant tissue-engineered vascular media can be produced when such scaffolds are used to culture smooth muscle cells (SMCs). The present study was designed to develop an anisotropic fibroblastic ECM sheet that could replicate the physiological architecture of blood vessels after being assembled into a small diameter vascular conduit. Anisotropic ECM scaffolds were produced using human dermal fibroblasts, grown on a microfabricated substrate with a specific topography, which led to cell alignment and unidirectional ECM assembly. Following their devitalization, the scaffolds were seeded with SMCs. These cells elongated and migrated in a single direction, following a specific angle relative to the direction of the aligned fibroblastic ECM. Their resultant ECM stained for collagen I and III and elastin, and the cells expressed SMC differentiation markers. Seven days after SMCs seeding, the sheets were rolled around a mandrel to form a tissue-engineered vascular media. The resulting anisotropic ECM and cell alignment induced an increase in the mechanical strength and vascular reactivity in the circumferential direction as compared to unaligned constructs. Copyright © 2016 John Wiley & Sons, Ltd.
- 1 September 2015
- Published by Elsevier in Acta Biomaterialia
- Vol. 24, 209-219
Human adipose-derived stromal cells for the production of completely autologous self-assembled tissue-engineered vascular substitutes
- 1 September 2015
- Published by Elsevier in Acta Biomaterialia
- Vol. 24, 209-219
Human adipose-derived stromal cells for the production of completely autologous self-assembled tissue-engineered vascular substitutes
- 1 May 2015
- Published by Elsevier in Acta Biomaterialia
- Vol. 18, 176-185
Mechanical properties of endothelialized fibroblast-derived vascular scaffolds stimulated in a bioreactor
- 1 May 2015
- Published by Elsevier in Acta Biomaterialia
- Vol. 18, 176-185
Mechanical properties of endothelialized fibroblast-derived vascular scaffolds stimulated in a bioreactor
- 1 November 2014
- Published by SAGE Publications in Tissue Engineering Part C: Methods
- Vol. 20 (11) , 905-915
A New Construction Technique for Tissue-Engineered Heart Valves Using the Self-Assembly Method
Tissue engineering appears as a promising option to create new heart valve substitutes able to overcome the serious drawbacks encountered with mechanical substitutes or tissue valves. The objective of this article is to present the construction method of a new entirely biological stentless aortic valve using the self-assembly method and also a first assessment of its behavior in a bioreactor when exposed to a pulsatile flow. A thick tissue was created by stacking several fibroblast sheets produced with the self-assembly technique. Different sets of custom-made templates were designed to confer to the thick tissue a three-dimensional (3D) shape similar to that of a native aortic valve. The construction of the valve was divided in two sequential steps. The first step was the installation of the thick tissue in a flat preshaping template followed by a 4-week maturation period. The second step was the actual cylindrical 3D forming of the valve. The microscopic tissue structure was assessed using histological cross sections stained with Masson's Trichrome and Picrosirius Red. The thick tissue remained uniformly populated with cells throughout the construction steps and the dense extracellular matrix presented corrugated fibers of collagen. This first prototype of tissue-engineered heart valve was installed in a bioreactor to assess its capacity to sustain a light pulsatile flow at a frequency of 0.5 Hz. Under the light pulsed flow, it was observed that the leaflets opened and closed according to the flow variations. This study demonstrates that the self-assembly method is a viable option for the construction of complex 3D shapes, such as heart valves, with an entirely biological material.
- 1 November 2014
- Published by SAGE Publications in Tissue Engineering Part C: Methods
- Vol. 20 (11) , 905-915
A New Construction Technique for Tissue-Engineered Heart Valves Using the Self-Assembly Method
Tissue engineering appears as a promising option to create new heart valve substitutes able to overcome the serious drawbacks encountered with mechanical substitutes or tissue valves. The objective of this article is to present the construction method of a new entirely biological stentless aortic valve using the self-assembly method and also a first assessment of its behavior in a bioreactor when exposed to a pulsatile flow. A thick tissue was created by stacking several fibroblast sheets produced with the self-assembly technique. Different sets of custom-made templates were designed to confer to the thick tissue a three-dimensional (3D) shape similar to that of a native aortic valve. The construction of the valve was divided in two sequential steps. The first step was the installation of the thick tissue in a flat preshaping template followed by a 4-week maturation period. The second step was the actual cylindrical 3D forming of the valve. The microscopic tissue structure was assessed using histological cross sections stained with Masson's Trichrome and Picrosirius Red. The thick tissue remained uniformly populated with cells throughout the construction steps and the dense extracellular matrix presented corrugated fibers of collagen. This first prototype of tissue-engineered heart valve was installed in a bioreactor to assess its capacity to sustain a light pulsatile flow at a frequency of 0.5 Hz. Under the light pulsed flow, it was observed that the leaflets opened and closed according to the flow variations. This study demonstrates that the self-assembly method is a viable option for the construction of complex 3D shapes, such as heart valves, with an entirely biological material.
- 1 May 2013
- Published by Elsevier in Cardiovascular Pathology
- Vol. 22 (3) , e50
A novel tissue-engineered devitalized vascular prosthesis
- 1 May 2013
- Published by Elsevier in Cardiovascular Pathology
- Vol. 22 (3) , e50
A novel tissue-engineered devitalized vascular prosthesis
- 1 May 2012
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 355 (1) , 87-95
Sex-specific perinatal expression of glutathione peroxidases during mouse lung development
- 1 May 2012
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 355 (1) , 87-95
Sex-specific perinatal expression of glutathione peroxidases during mouse lung development